Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2022

Upgrades

Benzinga

Preview: Simulations Plus's Earnings

Simulations Plus (NASDAQ:SLP) is set to give its latest quarterly earnings report on Wednesday, 2022-07-06. Here's what investors need to know before the announcement. Analysts estimate that Simulations Plus will report an earnings per share (EPS) of $0.17.

Benzinga

EXCLUSIVE: Greenwave Technology Solutions Clocks 56% Revenue Growth In Q2

Greenwave Technology Solutions, Inc. (OTC: GWAV) reported second-quarter revenue growth of 56% year-over-year to $10.70 million, above the previously predicted 40%. GWAV generated positive cash flows from operating activities for the six months ending June 30, 2022.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga Before The Bell: Record Inflows In 'Short Bitcoin' Funds, Elon Musk's Trillionaire Possibility, Gmail's Political Bias And Other Top Financial Stories Tuesday, July 5

Reuters

Benzinga

WeShop launches as first community-owned shopping platform with IPO in sight

British tech firm WeShop is launching itself as the world's first community-owned social ecommerce platform, offering shoppers shares in the group every time they make a purchase.

Evening Standard

Benzinga Bulls And Bears Of The Week: AMC, Coinbase, Apple, Tesla And The Crypto Everyone Is Watching

Benzinga has examined the prospects for many investors' favorite stocks over the past week, while offering a 24/7 news feed, live chat and charting software on Benzinga Pro.

Benzinga

Analysis: What's Playing In Russian Theaters In The Wake Of Hollywood's Boycott?

In the aftermath of Russia’s invasion of Ukraine, the Hollywood studios announced the withdrawal of their films from Russian theaters.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

MDNA: Encouraging CD8+ T Cell and NK Cell Responses in ABILITY Trial…

By David Bautz, PhD NASDAQ:MDNA READ THE FULL MDNA RESEARCH REPORT

Benzinga

Tesla Q2 Deliveries Hit By China Lockdowns, Yet June Production Highest On Record: Worst May Be Behind

Tesla, Inc. (NASDAQ: TSLA) reported second-quarter deliveries that declined sequentially, in line with expectations, as COVID lockdowns in China impacted performance.

Benzinga

BVXV: Significant Progress Made in NanoAb Program…

By David Bautz, PhD NASDAQ:BVXV READ THE FULL BVXV RESEARCH REPORT

Benzinga

Oil And Energy Leads Way: These Were The Top 10 S&P 500 Stocks In First Half Of 2022

The S&P 500 closed the month of June posting the worst half of a year since 1970 and the worst quarter since the first quarter of 2020, a period that included the official declaration of COVID-19 being a pandemic.

Benzinga

Tesla AI Job Cuts, Nio Stung By Short Report, Ford's F-150 Lightning Recall, Faraday Future The New Meme Stock In Town: Week's Top News From EV Industry

Electric vehicle stocks declined in the week ending July 1, taking cues from the retreat in the broader market. The S&P 500 Index fell in the first four sessions of the week amid economic worries, before coming back up in the final trading session, and yet ended the week lower. Company-specific…

Benzinga

SNGX: Bivalent Filovirus Vaccine Candidate Provides 100% Protection in Non-Human Primates…

By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT

Benzinga

Check Out What Whales Are Doing With PANW

Someone with a lot of money to spend has taken a bearish stance on Palo Alto Networks (NASDAQ:PANW). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Here's How Much $100 Invested In Starbucks 15 Years Ago Would Be Worth Today

Starbucks (NASDAQ:SBUX) has outperformed the market over the past 15 years by 6.44% on an annualized basis producing an average annual return of 12.72%. Currently, Starbucks has a market capitalization of $90.97 billion.

Benzinga

Video: Hacked Tesla Model S Plaid Goes Over 200 mph

Tesla Inc's (NASDAQ: TSLA) quickest car to date, the Model S Plaid, can go zero to 60 in 1.99 seconds. While the Model S Plaid is capped at a lower top speed of 175 mph, the car going 200 mph is advertised as coming soon with special hardware and a software unlock.

Benzinga

S&P 500 Finishes Off Worst First Half Of Any Year Since 1970

Stock prices dropped sharply this week as the SPDR S&P 500 ETF Trust (NYSE: SPY) completed its worst first half of any year in more than half a century.

Benzinga

Only 8 Of The 30 Dow Jones Stocks Were Positive In The First Half Of 2022: Chevron Leads, But Who Else Was Up?

The U.S. stock market had a rough start to 2022 with a market correction hitting stocks and many indexes seeing their worst performances in decades.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

6 Micron Analysts On Q3 Earnings: 'The Reset Was Generally Expected'

Micron Technology, Inc. (NASDAQ: MU) reported third-quarter results after the closing bell on Thursday. Here's what the Street has to say.

Benzinga

Cannabis Movers & Shakers: Canopy Growth, Flower One & Green Check Verified

Canopy Growth’s BioSteel Sports Names President Canopy Growth Corp.’s (NASDAQ: CGC) BioSteel Sports Nutrition Inc. has tapped Bruce Jacobson to serve as its president.

Benzinga

'How Do You Not Like Apple?': How CNBC's Todd Gordon Is Investing In A Volatile Market

Todd Gordon, CNBC contributor and founder of New Age Wealth Advisors, joined Benzinga's PreMarket Prep show on Friday morning. Gordon discussed the S&P 500 market weakness so far in 2022 and how he is positioning his clients' money heading into the second half of the year.

Benzinga

HC Wainwright Finds 'Synergies In Treatment' For This Bipolar-Focused Stock

HC Wainwright initiated coverage on NRx Pharmaceuticals Inc (NASDAQ:NRXP) with a Buying rating and a price target of $2. Earlier today, the FDA declined to issue an Emergency Use Authorization for NRx's Zyesami for a subgroup of patients who also received Gilead Sciences Inc's (NASDAQ:GILD) remdesivir in addition to Zyesami. The analyst is bullish on: Significant potential for NRX-101 for…

Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,400 Today

Seagen (NASDAQ:SGEN) has outperformed the market over the past 5 years by 18.41% on an annualized basis producing an average annual return of 27.81%. Currently, Seagen has a market capitalization of $32.98 billion.

Benzinga

Here's How Much You Would Have Made Owning SBA Communications Stock In The Last 15 Years

SBA Communications (NASDAQ:SBAC) has outperformed the market over the past 15 years by 9.87% on an annualized basis producing an average annual return of 16.12%. Currently, SBA Communications has a market capitalization of $35.46 billion.

Benzinga

Here's How Much $1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 14.19% on an annualized basis producing an average annual return of 21.3%. Currently, Regeneron Pharmaceuticals has a market capitalization of $65.05 billion.

1 … 359 360 361 362

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.